CHIEF OPERATING OFFICER · Adverum Biotechnologies, Inc. · Common Stock
Side
BUY
Value
$211K
Shares
50.0K
Price
$4.22
Executed
Dec 5, 2025
Disclosed
Dec 8, 2025
Disclosure timeline3 days from execution to publication · legal deadline 2 business days
Dec 5 executedDec 8, 2025 disclosed
ADVM · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Soparkar Peter filed this Form 4 reporting a open-market purchase of ADVM on Dec 5, 2025. It became public on Dec 8, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
CHIEF OPERATING OFFICER
Soparkar Petercik:0001736315
Issuer
Adverum Biotechnologies, Inc.cik:0001501756
Revision history · 0
No field has changed since this record was first ingested.
Company events
No records
No material filings recorded for this issuer.
Source error
Price history for ADVM is unavailable.
An error occurred in the Server Components render. The specific message is omitted in production builds to avoid leaking sensitive details. A digest property is included on this error instance which may provide additional details about the nature of the error.
